Shandong Linuo Pharmaceutical Packaging (301188.SZ) submitted an application to the Hong Kong Stock Exchange for the issuance and listing of overseas-listed foreign shares (H shares).
Linuo Pharmaceutical Packaging (301188.SZ) announced that on September 28, 2026, the Company submitted an application to The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") for the issuance and listing of overseas-listed foreign shares (H shares) on the Main Board of the Hong Kong Stock Exchange, and on the same day published the application materials for this issuance and listing on the website of the Hong Kong Stock Exchange.
Shandong Linuo Pharmaceutical Packaging (301188.SZ) announced that on September 28, 2026, the company submitted an application to The Stock Exchange of Hong Kong Limited (hereinafter referred to as the "Hong Kong Stock Exchange") for the issuance and listing of overseas-listed foreign shares (H shares) on the Main Board of the Hong Kong Stock Exchange, and on the same day published the application materials for this issuance and listing on the Hong Kong Stock Exchange website.
Related Articles
LEGENDARY EDU (08195) Enters into a Memorandum of Understanding with Lee Shing Chak Regarding Potential Cooperation to Organize a Series of Metaphysics Courses
New China Life Insurance (01336) will pay an interim dividend of RMB 0.73 per share on December 10.
ESSEX BIO-TECH (01061) repurchased 30,000 shares for HK$61,500 on September 28.
LEGENDARY EDU (08195) Enters into a Memorandum of Understanding with Lee Shing Chak Regarding Potential Cooperation to Organize a Series of Metaphysics Courses
New China Life Insurance (01336) will pay an interim dividend of RMB 0.73 per share on December 10.
ESSEX BIO-TECH (01061) repurchased 30,000 shares for HK$61,500 on September 28.
